Canada Life’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Canada Life’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$34K	–	2810
2018 Q3	$34K	Hold	10,000	–	–	﹤0.01%	2457
2018 Q2	$38K	Hold	10,000	–	–	﹤0.01%	2456
2018 Q1	$41K	Hold	10,000	–	–	﹤0.01%	2411
2017 Q4	$46K	Hold	10,000	–	–	﹤0.01%	2390
2017 Q3	$71K	Hold	10,000	–	–	﹤0.01%	2246
2017 Q2	$72K	Hold	10,000	–	–	﹤0.01%	2212
2017 Q1	$61K	Hold	10,000	–	–	﹤0.01%	2257
2016 Q4	$59K	Hold	10,000	–	–	﹤0.01%	2277
2016 Q3	$53K	Hold	10,000	–	–	﹤0.01%	2328
2016 Q2	$66K	Hold	10,000	–	–	﹤0.01%	2243
2016 Q1	$46K	Hold	10,000	–	–	﹤0.01%	2169
2015 Q4	$51K	Hold	10,000	–	–	﹤0.01%	2140
2015 Q3	$35K	Hold	10,000	–	–	﹤0.01%	2215
2015 Q2	$100K	Hold	10,000	–	–	﹤0.01%	1875
2015 Q1	$127K	Hold	10,000	–	–	﹤0.01%	1637
2014 Q4	$141K	Hold	10,000	–	–	﹤0.01%	1512
2014 Q3	$138K	Hold	10,000	–	–	﹤0.01%	1444
2014 Q2	$153K	Buy	+10,000	New	+$142K	﹤0.01%	1295

Canada Life's KERX Position: Q4 2018 in Review

Canada Life sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 10,000 shares — an estimated $34K sold.

Canada Life first reported a position in KERX in Q2 2014 and held it in 18 quarters. The position peaked at $153K in Q2 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Canada Life reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Canada Life sold 10,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $34K.
Canada Life first reported a position in Keryx Biopharmaceuticals Inc in Q2 2014 and held it in 18 quarters.
Canada Life's Keryx Biopharmaceuticals Inc position peaked at $153K in Q2 2014.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Canada Life's 13F filing for Q4 2018, filed 12 Feb 2019.